Executive Summary
•Elsight has crossed the profitability inflection: FY25 revenue of ~$23m (11x YoY), TTM revenue now $41.4m, but the 0.3% operating margin shows gross profit is still being ploughed into a global sales build, so the 22.8% net margin overstates underlying operating economics.
•Forward earnings power is being revised up hard: NTM EPS consensus has moved to $0.12 from a stale $0.03, implying a forward P/E closer to 25x than the headline 98x, on consensus NTM revenue of $57.6m, EBIT of $20.4m and FCF of $30.3m.
•The balance sheet is a genuine strategic asset: ~$59m cash, effectively no debt (D/E 3.0%), asset light contract manufacturing, and $22m of 2026 orders already locked, equal to 96% of FY25 revenue.
•Data quality is poor and the stock is volatile: reported prices of $2.95, $5.03 and $5.59 appear across the same window, and the relative valuation history rests on tiny samples (n=2 to 3), so cheapness versus own history is directional only.
Financial Snapshot
•Revenue (TTM): $41.4m
•Revenue (FY25): ~$23m (+11x YoY)
•Q1 2026 revenue: $11.6m (+12x YoY)
•Gross margin: 77.5%
•Operating margin: 0.3%
•Net margin: 22.8%
•ROE: 28.7%
•Debt/Equity: 3.0%
•Cash (end 2025): ~$59m
•Confirmed 2026 orders: $22m (96% of FY25 revenue)
•Cumulative pipeline: $137m (down from $157m on conversion)
•Current serviceable market: ~$250m, expanding toward multibillion
Forward Outlook
•Consensus NTM revenue: $57.6m, implying ~40% growth off the TTM base and ~150% off FY25
•Consensus NTM EBIT: $20.4m, a step change from the near breakeven operating margin today
•Consensus NTM EBITDA: $22.25m
•Consensus NTM net income: $17.95m
•BEST estimate NTM FCF: $30.27m, well ahead of net income, reflecting working capital release and low capex
•NTM EPS consensus: $0.12, versus a stale $0.03 in the spreadsheet, a 4x revision
•Forward EPS growth: 153.3%
•Margin trajectory: gross margin holding ~76 to 78%, with operating leverage driving EBIT margin from ~0.3% toward the mid 30s percent range if consensus is met
•Order book: $22m locked for 2026, giving unusually high revenue visibility for a company this size
Valuation Analysis
•Current price: $2.95 (as of 2026-10-27); 52 week range $1.32 to $8.56
•Market cap: $573.2m (Yahoo); note ASX Bloomberg fields show a $1k market cap and $1.18b EV, both internally inconsistent
•NTM P/E: ~24.6x on $0.12 EPS (the 98.33x headline uses the stale $0.03)
•NTM P/E on consensus net income ($17.95m / ~222m shares = ~$0.08): ~36x
•NTM P/S: ~10x ($573m market cap / $57.6m revenue)
•NTM EV/EBIT: ~16.6x (BF, trailing reported basis); ~29x on forward EV of ~$600m / $20.4m
•BF EV/EBITDA: 16.3x vs 2 year average 52.0x, implied price at average $8.53
•BF EV/EBIT: 16.6x vs 2 year average 46.3x, implied price at average $7.48
•BF EV/Rev: 7.1x vs 2 year average 8.8x, implied price at average $3.59
•LF P/BV: 7.2x vs 2 year average 21.6x, implied price at average $8.86
•PEG: ~0.16 on 25x forward P/E and 153% EPS growth, optically very low
•Consensus target price: $9.55
•AVAV: ~60 to 70x NTM P/E, defence uncrewed systems, premium on program backlog
•KTOS: ~40 to 50x NTM P/E, defence drones and targets, lower growth
•DRO.AX: high multiple, counter drone, closest ASX defence tech peer
•ONDS: loss making, drone connectivity and comms, no meaningful P/E
Key Risks & Catalysts
Risks
•Operating margin of 0.3% shows the model is not yet proving leverage; consensus EBIT of $20.4m is a large jump that may not land
•Net margin (22.8%) sits above operating margin, implying non operating or one off income is inflating headline profitability
•Pipeline fell to $137m from $157m; if conversion does not keep pace, top line growth stalls
•Customer concentration in defence and homeland security, with lumpy program based revenue
•Data quality is poor: conflicting prices, a $1k market cap field and a stale forward EPS undermine confidence in any single valuation anchor
•Forward P/S of ~10x leaves little room for a growth miss
•Small sample relative valuation history (n=2 to 3) makes the cheap versus history signal statistically weak
•Defence budget timing and procurement cycles are outside management control
Catalysts
•Conversion of the $137m pipeline into recognised revenue through 2026
•Delivery against the $22m of confirmed 2026 orders
•Further NTM EPS upgrades, given consensus has already moved from $0.03 to $0.12
•New senior business development hires across the US, Europe, Israel and Asia scaling defence and uncrewed systems sales
•Domain expansion from air into land and maritime, lifting value per system
•Software and subscription mix shift (recurring revenue up 11x YoY) improving earnings quality
•Continued NATO and allied defence budget increases toward 5% of GDP, with ringfenced uncrewed systems allocations
Investment Thesis
Elsight is a genuine category leader in a structurally growing niche: resilient beyond visual line of sight connectivity for uncrewed systems, sold into defence, homeland security and commercial robotics. The FY25 to 2026 numbers are striking, with revenue up 11x in FY25, a further 12x YoY in Q1 2026, 77.5% gross margins, ~$59m of cash and effectively no debt. The shift toward commercial off the shelf procurement and rising allied defence budgets give the Halo platform a credible multiyear runway, and the move from pure connectivity into mission enabling software and additional domains raises content per system.
The valuation debate turns entirely on which earnings number you trust. The headline 98x forward P/E uses a stale $0.03 EPS, while current consensus of $0.12 implies ~25x forward earnings and a PEG near 0.16 on 153% EPS growth. That is not expensive for a profitable, cash rich, high growth defence tech name, and on relative history the shares screen 60 to 70% below two year average multiples. The catch is that operating margin is still only 0.3%, so the consensus EBIT of $20.4m assumes operating leverage that has not yet been demonstrated, and the data set itself is inconsistent enough to warrant caution.
Net, constructive but disciplined. Accumulate on weakness toward the low $2s, where the risk reward on a ~25x forward multiple and $59m cash buffer is compelling. Base case fair value of $4.50 to $5.00, roughly 35 to 40x NTM EPS on the $0.12 consensus. The consensus target of $9.55 is a credible bull case if the pipeline converts and margins inflect, but it demands flawless execution. A break below $2.00, or evidence that the operating margin is not expanding through 2026, would invalidate the thesis.
